These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3607514

  • 1. Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation.
    Adem A, Mattsson ME, Nordberg A, Påhlman S.
    Brain Res; 1987 Jun; 430(2):235-42. PubMed ID: 3607514
    [Abstract] [Full Text] [Related]

  • 2. High-affinity [3H]pirenzepine binding to putative M1 muscarinic sites in the neuroblastoma x glioma hybrid cell line (NG 108-15).
    Akiyama K, Watson M, Roeske WR, Yamamura HI.
    Biochem Biophys Res Commun; 1984 Feb 29; 119(1):289-97. PubMed ID: 6546688
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Down-regulation of muscarinic receptors in the striatum of organophosphate-treated swine.
    Yang CM, Dwyer TM, Mohan PM, Ho IK, Farley JM.
    Toxicol Appl Pharmacol; 1990 Jul 29; 104(3):375-85. PubMed ID: 2385834
    [Abstract] [Full Text] [Related]

  • 7. Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1.
    Lambert DG, Ghataorre AS, Nahorski SR.
    Eur J Pharmacol; 1989 Jun 08; 165(1):71-7. PubMed ID: 2767136
    [Abstract] [Full Text] [Related]

  • 8. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P, Ebinger G, Vauquelin G.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4119-24. PubMed ID: 3689439
    [Abstract] [Full Text] [Related]

  • 9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 01; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 10. Muscarinic binding sites in a catecholaminergic human neuroblastoma cell line.
    Sorrentino G, Singh IN, Hubsch A, Kanfer JN, Mykita S, Massarelli R.
    Neurochem Res; 1992 Mar 01; 17(3):215-22. PubMed ID: 1320213
    [Abstract] [Full Text] [Related]

  • 11. Phorbol esters alter muscarinic receptor binding and inhibit polyphosphoinositide breakdown in human neuroblastoma (SH-SY5Y) cells.
    Serra M, Smith TL, Yamamura HI.
    Biochem Biophys Res Commun; 1986 Oct 15; 140(1):160-6. PubMed ID: 3022714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI.
    J Pharmacol Exp Ther; 1987 Jan 15; 240(1):51-8. PubMed ID: 3806397
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK.
    Brain Res; 1991 Feb 01; 540(1-2):145-52. PubMed ID: 1905173
    [Abstract] [Full Text] [Related]

  • 15. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
    Okayama M, Mullol J, Baraniuk JN, Hausfeld JN, Feldman B, Merida M, Shelhamer JH, Kaliner MA.
    Am J Respir Cell Mol Biol; 1993 Feb 01; 8(2):176-87. PubMed ID: 8427708
    [Abstract] [Full Text] [Related]

  • 16. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation.
    Påhlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T.
    Cell Differ; 1984 Jun 01; 14(2):135-44. PubMed ID: 6467378
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
    Mei L, Lai J, Roeske WR, Fraser CM, Venter JC, Yamamura HI.
    J Pharmacol Exp Ther; 1989 Feb 01; 248(2):661-70. PubMed ID: 2537406
    [Abstract] [Full Text] [Related]

  • 18. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec 01; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 19. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
    Murphy NP, McCormack JG, Ball SG, Vaughan PF.
    Biochem J; 1992 Mar 15; 282 ( Pt 3)(Pt 3):645-50. PubMed ID: 1554348
    [Abstract] [Full Text] [Related]

  • 20. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug 15; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.